These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

966 related articles for article (PubMed ID: 33180982)

  • 21. COVID-19: The experience from Italy.
    Recalcati S; Gianotti R; Fantini F
    Clin Dermatol; 2021; 39(1):12-22. PubMed ID: 33972039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2.
    Fertitta L; Welfringer-Morin A; Ouedrani A; Polivka L; Chhun S; Chatenoud L; Fourgeaud J; Hadj-Rabia S; Temmam S; Eloit M; Sermet-Gaudelus I; Bodemer C
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e164-e167. PubMed ID: 33010072
    [No Abstract]   [Full Text] [Related]  

  • 23. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    Nakashima C; Kato M; Otsuka A
    J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
    Damsky W; Peterson D; King B
    J Am Acad Dermatol; 2020 Sep; 83(3):e269-e270. PubMed ID: 32565206
    [No Abstract]   [Full Text] [Related]  

  • 26. New insights in COVID-19-associated chilblains: A comparative study with chilblain lupus erythematosus.
    Battesti G; El Khalifa J; Abdelhedi N; Ferre V; Bouscarat F; Picard-Dahan C; Brunet-Possenti F; Collin G; Lavaud J; Le Bozec P; Rousselot M; Tournier A; Lheure C; Couvelard A; Hacein-Bey-Abina S; Abina AM; Charpentier C; Mignot S; Nicaise P; Descamps D; Deschamps L; Descamps V
    J Am Acad Dermatol; 2020 Oct; 83(4):1219-1222. PubMed ID: 32622895
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular cutaneous manifestations of COVID-19 and RNA viral pathogens: a systematic review.
    Karch JL; Okorie CL; Maymone MBC; Laughter M; Vashi NA
    Clin Exp Dermatol; 2024 Mar; 49(4):313-324. PubMed ID: 37936304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatological Manifestations of COVID-19 in Children.
    Panda M; Agarwal A; Hassanandani T
    Indian Pediatr; 2022 May; 59(5):393-399. PubMed ID: 35273132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic.
    Colonna C; Genovese G; Monzani NA; Picca M; Boggio F; Gianotti R; Marzano AV
    J Am Acad Dermatol; 2020 Sep; 83(3):965-969. PubMed ID: 32534082
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
    Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
    JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains.
    Docampo-Simón A; Sánchez-Pujol MJ; Gimeno-Gascon A; Palazón-Cabanes JC; Juan-Carpena G; Vergara-De Caso E; González-Villanueva I; Blanes-Martínez M; Betlloch-Mas I
    Dermatol Ther; 2020 Nov; 33(6):e14332. PubMed ID: 32975345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients.
    Marzano AV; Genovese G; Moltrasio C; Gaspari V; Vezzoli P; Maione V; Misciali C; Sena P; Patrizi A; Offidani A; Quaglino P; Arco R; Caproni M; Rovesti M; Bordin G; Recalcati S; Potenza C; Guarneri C; Fabbrocini G; Tomasini C; Sorci M; Lombardo M; Gisondi P; Conti A; Casazza G; Peris K; Calzavara-Pinton P; Berti E;
    J Am Acad Dermatol; 2021 May; 84(5):1356-1363. PubMed ID: 33476725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of association between pandemic chilblains and SARS-CoV-2 infection.
    Gehlhausen JR; Little AJ; Ko CJ; Emmenegger M; Lucas C; Wong P; Klein J; Lu P; Mao T; Jaycox J; Wang E; ; Ugwu N; Muenker C; Mekael D; Klein RQ; Patrignelli R; Antaya R; McNiff J; Damsky W; Kamath K; Shon J; Ring AM; Yildirim I; Omer S; Ko AI; Aguzzi A; Iwasaki A
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35217624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review.
    Kolivras A; Thompson C; Pastushenko I; Mathieu M; Bruderer P; de Vicq M; Feoli F; Harag S; Meiers I; Olemans C; Sass U; Dehavay F; Fakih A; Lam-Hoai XL; Marneffe A; Van De Borne L; Vandersleyen V; Richert B
    J Cutan Pathol; 2022 Jan; 49(1):17-28. PubMed ID: 34272741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
    Nyasulu PS; Tamuzi JL
    Int J Dermatol; 2024 Jan; 63(1):10-22. PubMed ID: 37965793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronavirus (COVID-19) Infection-Induced Chilblains: A Brisk Perieccrine Inflammatory Response.
    Wargo JJ; Weir NM; Shamma HN
    Am J Dermatopathol; 2021 Feb; 43(2):144-145. PubMed ID: 32618705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19.
    Gallizzi R; Sutera D; Spagnolo A; Bagnato AM; Cannavò SP; Grasso L; Guarneri C; Nunnari G; Mazza F; Pajno GB
    Dermatol Ther; 2020 Nov; 33(6):e14312. PubMed ID: 32949449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous Manifestations of SARS-CoV-2 Infection.
    Huynh T; Sanchez-Flores X; Yau J; Huang JT
    Am J Clin Dermatol; 2022 May; 23(3):277-286. PubMed ID: 35247198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous signs in COVID-19 patients: A review.
    Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
    Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.